HQL-79 是一种有效、选择性、可口服的人造血前列腺素 D 合成酶 (hematopoietic prostaglandin D synthase (H-PGDS)) 抑制剂，高度选择性地抑制 PGD2 的合成，为抗过敏剂，对 H-PGDS 的 Kd 值为 0.8 μM，IC50 值为 6 μM。对 COX-1，COX-2，m-PGES 或 L-PGDS 等无作用。
| 生物活性 |
HQL-79, a potent, selective and orally active human hematopoietic prostaglandin D synthase (H-PGDS) inhibitor, highly selectively inhibits the synthesis of PGD2, and acts as an anti-allergic agent, with a Kd of 0.8 μM and an IC50 of 6 μM. Shows no obvious effect on COX-1, COX-2, m-PGES, or L-PGDS. |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 体外研究 |
HQL-79 is a competitive inhibitor against substrate PGH2 and a non-competitive one against GSH. |
||||||||||||
| 分子式 |
C22H27N5O
|
||||||||||||
| 分子量 |
377.48
|
||||||||||||
| CAS号 |
162641-16-9
|
||||||||||||
| 运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||
| 储存方式 |
|
纯度： 98%
关注我们
获得KKL MED 最新资讯
客服小K 
客服小K
Data Sheet